Effect of Siravedha with Dadrughna lepa in Dadru kushtha (Tinea corporis).

A randomised open-label controlled clinical trial to study the add-on effect of Siravedha with Dadrughna lepa in the management of Dadru kushtha with special reference to Tinea corporis. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101506

Enrollment

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Dadru Kushtha (i.e., itching, circular lesions, burning sensation, vesicles) will be selected irrespective of gender. Individuals aged between 18 and 60 years Patients assessed as fit for Siravedha

Exclusion criteria

Exclusion criteria: Siravedh should be avoided in the following conditions: Severe anemia or hemoglobin deficiency Uncontrolled diabetes mellitus Pregnancy or active menstrual bleeding Immunocompromised patients Open wounds or generalized infections Patients currently on anticoagulant medications Individuals with bleeding disorders such as haemophilia

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of Dadru kushthaTimepoint: 15 days	—

Secondary

Measure	Time frame
Where the trial group stands in comparison with control groupTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Rushikesh Jaysing Gund

SMBT Ayurved College and Hospital

vdpramod31@gmail.com9604633832

Outcome results